Drug Susceptibility Test and Analysis of Quinolone Resistance Genes in Mycoplasma hyopneumoniae Vaccine Strains and Field Isolates from China
Yapei Rui,Gang Qiu
DOI: https://doi.org/10.2147/IDR.S407579
2023-04-08
Infection and Drug Resistance
Abstract:Yapei Rui, Gang Qiu College of Animal Science and Veterinary Medicine, Xinyang Agriculture and Forestry University, Xinyang, Henan, People's Republic of China Correspondence: Gang Qiu, Email Background: Enrofloxacin is a commonly used animal-specific drug in veterinary clinics. However, this drug has no epidemiological cutoff values (ECVs/ECOFFs) for Mycoplasma hyopneumoniae in CLSI and EUCAST. Defining the epidemiological cutoff values (ECOFFs) of enrofloxacine to Mycoplasma hyopneumoniae (M. hyo) can inform an early detection of bacterial resistance to better manage the resistance prevention and also help in establishing drug resistance breakpoints;. Methods: We determined the susceptibility breakpoint of M. hyo to enrofloxacin by the American Clinical and Laboratory Standards Institute (CLSI) standard method based on the PCR of vaccine strains and wild strains drug resistance genes;. Results: Eighty strains of M.hyo isolated in Tibet were moderately sensitive (S) to tetracycline, florfenicol, spiramycin, erythromycin thiocyanate, tilmicosin, tiamulin, lincomycin, clindamycin, ofloxacin, enrofloxacin, gentamicin, amikacin, with MICs below 0.5 μg/mL. For vaccine 168L, RM48, and J strains, the susceptibility to the same antibacterial drugs was lower compared to the Tibetan isolates. The resistance of J strain to erythromycin thiocyanate was confirmed. Gene point mutation was confirmed in Quinolone Resistance Determining Regions (QRDR) of HNSH strain Topoisomerase IV subunit A, this finding is compared with the sequencing results of 168L strain reference sequence (Accession number: CP003131). Arg-Lys amino acid mutation (G921A and G1179A) was confirmed for the increase of MIC value involved in M.hyo to enrofloxacine;. Conclusion: The cut-off value of M.hyo to enrofloxacin was set as 1 μg/mLby ECOFFinder XL 2010 V2.1. Keywords: Mycoplasma hyopneumoniae , drug resistance, Tibetan pigs, MIC, enrofloxacin Although imported and domestic vaccines prevented M. hyo infection in P. R. China, there is no clinical vaccine that can 100% prevent and control M. hyo infection in Tibetan pigs, possibly because of the gene variation in this species. According to reports from China and abroad, antimicrobial drugs have always played an irreplaceable role in preventing and treating swine enzootic pneumonia. 1–5 High MIC values of fluoroquinolones (enrofloxacin 2.5 μg/mL; marbofloxacin 5 μg/mL) were observed against one M.hyo strain (MycSu17) by Felde, O. et al. 6 Due to the long-term low-dose prophylaxis and high-dose medications, 7 the resistance of Mycoplasmas (including M. hyo ) to antimicrobials is becoming more widespread, 8 bringing severe challenges to the prevention and control of M.hyo in P. R.China. Epidemiological survey results have demonstrated the prevalence of Mycoplasma pneumonia of swine (MPS) in Tibetan pig herds to be 20.48% to 50% 9 in the Qinghai-Tibet Plateau. MPS reduced the growth rate of Tibetan pigs, causing considerable losses to the Tibetan pig-breeding industry. However, there are relatively few basic data on drug susceptibility of M.hyo in Tibetan pigs by searching public databases. The resistance of M.hyo to fluoroquinolones is becoming more widespread in China, with fluoroquinolones treatment failures occurring more frequently in veterinary clinics. Quinolones target DNA gyrase, an essential enzyme in bacterial replication that generates negative and positive supercoils in DNA by transiently introducing double-stranded breaks in an ATP-dependent reaction. DNA gyrase is a heterotetramer consisting of two A and two B subunits, respectively. 10,11 The drug resistance mechanism includes a quinolone resistance-determining region (QRDR) target gene mutation, 12–16 plasmid-mediated quinolone resistance (PMQR) gene, 17 the efflux pump, 18 transferable multidrug resistance element, and other not bacteria to be discovered. 19 China is strengthening the monitoring of the drug resistance of animal-derived microorganisms, especially bacteria; the monitoring needs to formulate relevant drug resistance determination standards. The International Research Programme on Comparative Mycoplasmology (IRPCM) proposed as early as 2000 the antibacterial drug susceptibility testing on animal mycoplasmas. 20 However, only a few animal mycoplasmas have been tested for antimicrobial susceptibility due to various factors including the different media and the protracted cultivation process of animal mycoplasmas. A unified susceptibility breakpoint standard has not yet been established. 21 At present, many coun -Abstract Truncated-
pharmacology & pharmacy,infectious diseases